» Articles » PMID: 38139295

Molecular Mechanisms Linking Diabetes with Increased Risk of Thrombosis

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2023 Dec 23
PMID 38139295
Authors
Affiliations
Soon will be listed here.
Abstract

This review will provide an overview of what is currently known about mechanisms linking poor glycaemic control with increased thrombotic risk. The leading causes of death in people with diabetes are strokes and cardiovascular disease. Significant morbidity is associated with an increased risk of thrombosis, resulting in myocardial infarction, ischaemic stroke, and peripheral vascular disease, along with the sequelae of these events, including loss of functional ability, heart failure, and amputations. While the increased platelet activity, pro-coagulability, and endothelial dysfunction directly impact this risk, the molecular mechanisms linking poor glycaemic control with increased thrombotic risk remain unclear. This review highlights the complex mechanisms underlying thrombosis prevalence in individuals with diabetes and hyperglycaemia. Post-translational modifications, such as O-GlcNAcylation, play a crucial role in controlling protein function in diabetes. However, the role of O-GlcNAcylation remains poorly understood due to its intricate regulation and the potential involvement of multiple variables. Further research is needed to determine the precise impact of O-GlcNAcylation on specific disease processes.

Citing Articles

Molecular Research on Diabetes.

Puddu A, Maggi D Int J Mol Sci. 2025; 26(5).

PMID: 40076500 PMC: 11899755. DOI: 10.3390/ijms26051873.


Therapeutic Effects of Lavender Oil on Streptozotocin-Induced Diabetes Mellitus and Experimental Thrombosis.

But V, Rus V, Ilyes T, Gherman M, Stanescu I, Bolboaca S Antioxidants (Basel). 2025; 14(2).

PMID: 40002353 PMC: 11851820. DOI: 10.3390/antiox14020166.

References
1.
Snow C, Senior A, Gerace L . Monoclonal antibodies identify a group of nuclear pore complex glycoproteins. J Cell Biol. 1987; 104(5):1143-56. PMC: 2114474. DOI: 10.1083/jcb.104.5.1143. View

2.
Maynard J, Chalkley R . Methods for Enrichment and Assignment of N-Acetylglucosamine Modification Sites. Mol Cell Proteomics. 2020; 20:100031. PMC: 8724609. DOI: 10.1074/mcp.R120.002206. View

3.
Pechlivani N, Ajjan R . Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets. Front Cardiovasc Med. 2018; 5:1. PMC: 5780411. DOI: 10.3389/fcvm.2018.00001. View

4.
Chung A, Jurasz P, Hollenberg M, Radomski M . Mechanisms of action of proteinase-activated receptor agonists on human platelets. Br J Pharmacol. 2002; 135(5):1123-32. PMC: 1573223. DOI: 10.1038/sj.bjp.0704559. View

5.
Cefalu W, Schneider D, Carlson H, Migdal P, Gan Lim L, Izon M . Effect of combination glipizide GITS/metformin on fibrinolytic and metabolic parameters in poorly controlled type 2 diabetic subjects. Diabetes Care. 2002; 25(12):2123-8. DOI: 10.2337/diacare.25.12.2123. View